The defining feature of CML is the Philadelphia chromosome, a genetic anomaly resulting from a translocation between chromosomes 9 and 22, which leads to the formation of the BCR::ABL fusion gene. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.